课题基金 / 基金详情

Investigating the function of the non-receptor tyrosine kinase, SRMS

Investigating the function of the non-receptor tyrosine kinase, SRMS
研究非受体酪氨酸激酶 SRMS 的功能
批准号:
RGPIN-2017-05564
负责人:
Lukong, Kiven
金额:
$1.82万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-01-01 至 2018-12-31

项目摘要

项目成果

Lukong, Kiven的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Tyrosine kinases are enzymes that control various biological processes that underlie overall cell and organismal growth. Cell growth, division, motility, and differentiation are key examples of such processes regulated by tyrosine kinases. Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristoylation sites (SRMS) is a tyrosine kinase that is conserved across many species, including humans, mice, and zebra fish. It is also the least studied and understood of the 90 known tyrosine kinases expressed in vertebrate species. SRMS is a member a non-receptor type tyrosine kinase family known as the BRK family kinases (BFKs). BRK (Breast tumor kinase, gene name PTK6) and FRK (Fyn-related kinase) are the other two proteins that belong to this family. Both PTK6 and FRK have been extensively characterized and shown to play key cellular roles in the context of cell growth and motility. The cellular and physiological roles of SRMS, on the other hand, remain largely unknown. In 2013, our group published the first biochemical study and revealed that (a) the 50 amino-acid long N-terminal region of the SRMS protein regulates its enzymatic activity and (b) Dok1 is the first bona fide cellular substrate of SRMS. Here, I propose a new program that seeks to decipher the cellular and biochemical role of SRMS by identifying the SRMS substrates/regulated proteins (phosphoproteomics) via quantitative mass spectrometry analyses. We also aim to characterize PTK6 as a SRMS. The validation and characterization of the hits is the major part of the short-term goals of the program, which will involve current and future trainees and will all be conducted in my laboratory. We will validate and characterize the SRMS targets using a myriad of molecular techniques employed in my laboratory, such as reciprocal immunoprecipitation, GST-pulldown assays, site-directed mutagenesis, in vitro kinase assays, and confocal immunofluorescence microscopy, to name a few. Therefore, here I propose to accelerate my existing research program on SRMS and thus meaningfully contribute to a career-long goal of understanding the cellular and physiological role of SRMS and how the function of SRMS differs from PTK6, FRK, and other tyrosine kinases. Our long-term goals specific to SRMS involve developing and adapting applied proteomics knowledge using high-throughput peptide-microarrays towards understanding SRMS-regulated signalosomes. We further propose to cumulatively employ these proteomics strategies towards understanding the cellular kinetics, associated signaling pathways, and mechanism of function, all in the context of investigating the cellular and physiological roles of the BFKs. Overall, these studies can be further adapted to understand how the role of SRMS impacts vertebrate biology at large.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the function of the non-receptor tyrosine kinase, SRMS
  • 批准号:
    RGPIN-2017-05564
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Lukong, Kiven
  • 依托单位:
Investigating the function of the non-receptor tyrosine kinase, SRMS
  • 批准号:
    RGPIN-2017-05564
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.82万
  • 财政年份:
    2020
  • 负责人:
    Lukong, Kiven
  • 依托单位:
Investigating the function of the non-receptor tyrosine kinase, SRMS
  • 批准号:
    RGPIN-2017-05564
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.82万
  • 财政年份:
    2019
  • 负责人:
    Lukong, Kiven
  • 依托单位:
Investigating the function of the non-receptor tyrosine kinase, SRMS
  • 批准号:
    RGPIN-2017-05564
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.82万
  • 财政年份:
    2018
  • 负责人:
    Lukong, Kiven
  • 依托单位:
国内基金
海外基金
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
  • 批准号:
    82371651
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵栋
  • 依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
  • 批准号:
    82370798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王晓
  • 依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
  • 批准号:
    82370851
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    包玉倩
  • 依托单位: